Pin1 overexpression is associated with poor differentiation and survival in oral squamous cell carcinoma

Oncology Reports

Volumn 21, Issue 4, 2009, Pages 1097-1104

  Leung, Kam Wing ^a,c   Tsai, Chen Hsun ^a   Hsiao, Michael ^b   Tseng, Ching Juinn ^a   Ger, Luo Ping ^a   Lee, Kuen Haur ^d   Lu, Pei Jung ^d  

^a KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b GENOMICS RESEARCH CENTER   (Taiwan)

^c YUAN'S GENERAL HOSPITAL   (Taiwan)

^d NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

catenin; Cyclin D1; Oral squamous cell carcinoma; Pin1; Survival

Indexed keywords

BETA CATENIN; CYCLIN D1; MESSENGER RNA; PEPTIDYLPROLYL ISOMERASE PIN1; REGULATOR PROTEIN; NIMA INTERACTING PEPTIDYLPROLYL ISOMERASE; NIMA-INTERACTING PEPTIDYLPROLYL ISOMERASE; PEPTIDYLPROLYL ISOMERASE;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; CELL DIFFERENTIATION; CELL SURVIVAL; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MOLECULAR BIOLOGY; MOUTH CANCER; ORAL SQUAMOUS CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; UPREGULATION; CHEMISTRY; MIDDLE AGED; MORTALITY; MOUTH TUMOR; PATHOLOGY; PHYSIOLOGY; PROGNOSIS;

ADULT; AGED; BETA CATENIN; CARCINOMA, SQUAMOUS CELL; CELL DIFFERENTIATION; CELL SURVIVAL; CYCLIN D1; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; MOUTH NEOPLASMS; PEPTIDYLPROLYL ISOMERASE; PROGNOSIS;

EID: 67449089557     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or_00000329     Document Type: Article

References (40)

1. Lu KP, Liou YC and Zhou XZ: Pinning down the proline-directed phosphorylation signaling. Trends Cell Biol 12: 164-172, 2002.
2. Wulf G, Finn G, Suizu F and Lu KP: Phosphorylation-specific prolyl isomerization: is there an underlying theme? Nat Cell Biol 7: 435-441, 2005.
3. Lu KP, Hanes SD and Hunter T: A human peptidyl-prolyl isomerase essential for regulation of mitosis. Nature 380: 544-547, 1996.
4. Yaffe MB, Schutkowski M, Shen M, Zhou XZ, Stukenberg PT, Rahfeld J, Xu J, Kuang J, Kirschner MW, Fischer G, Cantley LC and Lu KP: Sequencespecific and phosphorylation-dependent proline isomerization: a potential mitotic regulatory mechanism. Science 278: 1957-1960, 1997.
5. Winkler KE, Swenson KI, Kornbluth S and Means AR: Requirement of the prolyl isomerase Pin1 for the replication checkpoint. Science 287: 1644-1647, 2000.
6. Ranganathan R, Lu KP, Hunter T and Noel JP: Structural and functional analysis of the mitotic peptidyl-prolyl isomerase Pin1 suggests that substrate recognition is phosphorylation dependent. Cell 89: 875-886, 1997.
7. Lu PJ, Zhou XZ, Shen M and Lu KP: A function of WW domains as phosphoserine- or phosphothreonine-binding modules. Science 283: 1325-1328, 1999.
8. Verdecia MA, Bowman ME, Lu KP, Hunter T and Noel JP: Structureal basis for phosphoserine-proline recognition by group IV WW domain. Nat Struct Biol 7: 639-643, 2000.
9. Shen M, Stukenberg PT, Kirschner MW and Lu KP: The essential mitotic peptidyl-prolyl isomerase Pin1 binds and regulates mitosis-specific phosphoproteins. Genes Dev 12: 706-720, 1998.
10. Zacchi P, Gostissa M, Uchida T, Salvagno C, Avolio F, Volinia S, Ronai Z, Blandino G, Schneider C and Del Sal G: The prolyl isomerase Pin1 reveals a mechanism to control p53 functions after genotoxic insults. Nature 419: 853-857, 2002.
11. Zheng H, You H, Zhou XZ, Murray SA, Uchida T, Wulf G, Gu L, Tang X, Lu KP and Xiao ZX: The prolyl isomerase Pin1 is a regulator of p53 in genotoxic response. Nature 419: 849-853, 2002.
12. Lu PJ, Wulf G, Zhou XZ, Davies P and Lu KP: The prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated tau protein. Nature 419: 784-788, 1999.
13. Zhou XZ, Kops O, Werner A, Lu PJ, Shen M, Stoller G, Küllertz G, Stark M, Fischer G and Lu KP: Pin1-dependent prolyl isomerization regulates dephosphorylation of Cdc25C and tau proteins. Mol Cell 6: 873-883, 2000.
14. Stukenberg PT and Kirschner MW: Pin1 acts catalytically to promote a conformational change in Cdc25. Mol Cell 7: 1071-1083, 2001.
15. Ryo A, Nakamura N, Wulf G, Liou YC and Lu KP: Pin1 regulates turnover and subcellular localization of beta-catenin by inhibiting its interaction with APC. Nat Cell Biol 3: 793-801, 2001.
16. Wulf GM, Ryo A, Wulf GG, Lee SW, Niu T and Lu KP: Pin1 is overexpressed in breast cancer and potentiates the transcriptional activity of phosphorylated c-Jun towards the cyclin D1 gene. EMBO J 20: 3459-3472, 2001.
17. Bao L, Kimzey A, Sauter G, Sowadski JM, Lu KP and Wang DG: Prevalent overexpression of prolyl isomerase Pin1 in human cancers. Am J Pathol 164: 1727-1737, 2004.
18. Ayala G, Wang DG, Wulf G, Frolov A, Li R, Sowadski J, Wheeler TM, Lu KP and Bao L: The prolyl isomerase Pin1 is a novel prognostic marker in human prostate cancer. Cancer Res 63: 6244-6251, 2003.
19. Pang R, Yuen J, Yuen MF, Lai CL, Lee TK, Man K, Poon RT, Fan ST, Wong CM, Ng IO, Kwong YL and Tse E: Pin1 overexpression and β-catenin gene mutationare distinct ongogenic events in human hepatocellular carcinoma. Oncogene 23: 4182-4186, 2004.
20. Wulf G, Garg P, Liou YC, Iglehart D and Lu KP: Modeling breast cancer in vivo and ex vivo reveals an essential role of Pin1 in tumorigenesis. EMBO J 23: 3397-3407, 2004
21. Baldin V, Lukas J, Marcote MJ, Pagano M and Draetta G: Cyclin D1 is a nuclear protein required for cell cycle progression in G1. Genes Dev 7: 812-821, 1993.
22. Lukas J, Pagano M, Staskova Z, Draetta G and Bartek J: Cyclin D1 protein oscillates and is essential for cell cycle progression in human tumor cell lines. Oncogene 9: 707-718, 1994.
23. Xu L, Davidson BJ, Murty VV, Li RG, Sacks PG and Garin-Chesa P: TP53 gene mutations and CCND1 gene amplification in head and neck squamous cell carcinoma cell lines. Int J Cancer 59: 383-387, 1994.
24. Bartkova J, Lukas J, Muller H, Strauss M, Gusterson B and Bartek J: Abnormal patterns of D-type cyclin expression and G1 regulation in human head and neck cancer. Cancer Res 55: 949-956, 1995.
25. Adelaide J, Monges G, Derderian C, Seitz JF and Birnbaum D: Oesophageal cancer and amplification of the human cyclin D gene CCND1/PRAD1. Br J Cancer 71: 64-68, 1995.
26. Sauter ER, Nesbit M, Litwin S, Klein-Szanto AJ, Cheffetz S and Herlyn M: Antisense cyclin D1 induces apoptosis and tumor shrinkage in human squamous carcinomas. Cancer Res 59: 4876-4881, 1999.
27. Masuda M, Hirakawa N, Nakashima T, Kuratomi Y and Komiyama S: Cyclin D1 overexpression in primary hypopharyngeal carcinomas. Cancer 78: 390-395, 1996.
28. Akervall JA, Michalides RJ, Mineta H, Balm A, Borg A and Dictor MR: Amplification of cyclin D1 in squamous cell carcinoma of the head and neck and the prognostic value of chromosomal abnormalities and cyclin D1 overexpression. Cancer 79: 380-389, 1997.
29. Kyomoto R, Kumazawa H, Toda Y, Sakaida N, Okamura A and Iwanaga M: Cyclin-D1-gene amplification is a more potent, prognostic factor than its protein overexpression in human headand-neck squamous-cell carcinoma. Int J Cancer 74: 576-581, 1997.
30. Michalides RJ, van Veelen NM, Kristel PM, Hart AA, Loftus BM and Hilgers FJ: Overexpression of cyclin D1 indicates a poor prognosis in squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 123: 497-502, 1997.
31. Mineta H, Miura K, Takebayashi S, Ueda Y, Misawa K and Harada H: Cyclin D1 overexpression correlates with poor prognosis in patients with tongue squamous cell carcinoma. Oral Oncol 36: 194-198, 2000.
32. Nakahara Y, Shintani S, Mihara M, Kiyota A, Ueyama Y and Matsumura T: Alterations of Rb, p16 (INK4A) and cyclin D1 in the tumorigenesis of oral squamous cell carcinomas. Cancer Lett 160: 3-8, 2000.
33. Lu PJ, Zhou XZ, Liou YC, Noel JP and Lu KP: Critical role of WW domain phosphorylation in regulating phosphoserine binding activity and Pin1 function. J Biol Chem 277: 2381-2384, 2002.
34. Ryo A, Liou YC, Wulf G, Nakamura N, Lee SW and Lu KP: Pin1 is an E2F target gene essential for the Neu/Ras-induced transformation of mammary epithelial cells. Mol Cell Biol 22: 5281-5295, 2002.
35. Alt JR, Cleveland JL, Hannink M and Diehl JA: Phosphorylation-dependent regulation of cyclin D1 nuclear export and cyclin D1-dependent cellular transformation. Genes Dev 14: 3102-3114, 2000.
36. Ryo A, Suizu F, Yoshida Y, Perrem K, Liou YC, Wulf G, Rottapel R, Yamaoka S and Lu KP: Regulation of NF-kappaB signaling by Pin1-dependent prolyl isomerization and ubiquitin-mediated proteolysis of p65/RelA. Mol Cell 6: 1413-1426, 2003.
37. Liou YC, Ryo A, Huang HK, Lu PJ, Bronson R, Fujimori F, Uchida T, Hunter T and Lu KP: Loss of Pin1 function in the mouse causes phenotypes resembling cyclin D1-null phenotypes. Proc Natl Acad Sci USA 99: 1335-1340, 2002.
38. Fujimori F, Takahashi K, Uchida C and Uchida T: Mice lacking Pin1 develop normally, but are defective in entering cell cycle from G(0) arrest. Biochem Biophys Res Commun 265: 658-663, 1999.
39. Ashita MH, Uchida T, Mori S, Echigo S and Motegi K: Expression status of Pin1 and cyclins in oral squamous cell carcinoma: Pin1 correlates with Cyclin D1 mRNA expression and clinical significance of cyclins. Oncol Rep 10: 1045-1048, 2003.
40. Miyashita H, Mori S, Motegi K, Fukumoto M and Uchida T: Pin1 is overexpressed in oral squamous cell carcinoma and its levels correlate with cyclin D1 overexpression. Oncol Rep 10: 455-461, 2003.